Status:
COMPLETED
Post Intensive Care Syndrome in COVID19 Patients
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
COVID19
Post Intensive Care Unit Syndrome
Eligibility:
All Genders
18-90 years
Brief Summary
This project is based in the implementation of a combined monitoring system (technological solutions and medical visits) in survivors of the critical illness due to the infectious disease by COVID-19....
Eligibility Criteria
Inclusion
- Patients admitted to ICU for COVID 19
Exclusion
- Mental health diagnosis previous to the COVID19 infection
- Acquired brain damage or neurological disease previous to the COVID19 infection
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04422444
Start Date
June 1 2020
End Date
June 1 2022
Last Update
March 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corporació Parc Taulí
Sabadell, Barcelona, Spain, 08208